Status:

COMPLETED

Choice Sets for Advance Directives

Lead Sponsor:

University of Pennsylvania

Conditions:

End Stage Renal Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

There is a large gap between the care seriously ill patients want and the care they receive. Advance directives (ADs) offer an opportunity for patients to express specific end-of-life preferences to a...

Detailed Description

This study has been designed as two sequential randomized trials to test two separate expanded choice set interventions, with the second randomization enrollment being contingent on results from the f...

Eligibility Criteria

Inclusion

  • Age 18 or older
  • Proficient in English
  • Chronic hemodialysis for minimum 90 days
  • Does not currently have a living will

Exclusion

  • Blindness
  • Cognitive impairment that prohibits subject's provision of informed consent

Key Trial Info

Start Date :

July 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2015

Estimated Enrollment :

321 Patients enrolled

Trial Details

Trial ID

NCT02209038

Start Date

July 1 2014

End Date

October 1 2015

Last Update

January 7 2016

Active Locations (15)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (15 locations)

1

Lourdes-Camden

Camden, New Jersey, United States, 08103

2

Market Street DaVita

Philadelphia, Pennsylvania, United States, 19104

3

Philadelphia 42nd Street DaVita

Philadelphia, Pennsylvania, United States, 19104

4

Philadelphia PMC-Lombard DaVita

Philadelphia, Pennsylvania, United States, 19104